A degree of reporting bias may exist in the sample that responded to our questionnaire and this may have skewed the results. We believe this to be limited as our purpose was to explore individual experiences and determine if there was a general consensus among the array of measures that exists.
Myokymia is a manifestation of peripheral nerve disease and classified as excess motor unit activity. Electrophysiologically, it consists of rhythymic or semirhythymic bursts of grouped motor unit potentials occurring at a uniform rate of 2-60 Hz, usually with 2-10 U within a burst. 1, 2 We present a 23-year-old lady who presented with left upper eyelid ptosis caused by orbicularis myokymia and treated with botulinum toxin injection.
Case report
A 23-year-old systemically healthy lady presented with complaints of ptosis of the left upper eyelid, present persistently since 3 months.
On examination, the best-corrected visual acuity was 6/6, in both eyes. The left upper eyelid was 1 mm lower in position and the lower eyelid was 1 mm raised, compared to the right eye. There was increased tone noted in the lower eyelid pretarsal orbicularis ( Figure 1a) . The left upper eyelid showed the presence of constant, rhythmic, fibrillations. The ptosis was constant, on evaluation on three different days, for an hour each. Postclosure, the upper eyelid was also slower to open. The levator action was 15 mm and the lid crease height was 8 mm, in both eyes. Remaining ocular examination was unremarkable.
Magnetic resonance imaging of the central nervous system was unremarkable. Special attention was paid to the VII nerve complex and the cerebropontine angle to rule out a dolichoectatic basilar vessel compression on the VII nerve, as a possible cause. Electro-myography of the left orbicularis muscle was performed and demonstrated over-activity (Figure 1b) .
The patient was diagnosed to not only have upper eyelid ptosis, but also reversed ptosis of the lower eyelid; due to increased tone of the orbicularis oculi.
A total of 5 U of botulinum toxin -A injection (Botox, Allergan, Irvine, CA) was given in two locations, intradermally and pretarsally, to the left upper eyelid and to the lower lid, respectively. The orbicularis activity subsided completely within a week and the ptosis was corrected completely (Figure 2 ).
The patient was followed-up at 3 monthly intervals and there was no recurrence of the ptosis, on last followup, a year later.
Discussion
Overactivity of the orbicularis oculi presents with a reduced palpebral aperture simulating ptosis, due to a disparity between the eyelid closing (orbicularis oculi) and eyelid opening (levator palpebrae superioris) muscles. Treatment consists of botulinum toxin injection to paralyse the orbicularis oculi. Injection needs to be given carefully, as if it is given too deep in the pretarsal area, spread of the drug to the underlying Muller's muscle may actually worsen ptosis. This was especially important, as our patient was cosmetically extremely conscious. Postinjection massage should be avoided to prevent deeper migration of the drug.
To summarize, we report the case of a 23-year-old lady with orbicularis myokymia causing unilateral mild ptosis, treated successfully with botulinum toxin injection. 
